Last updated: February 20, 2026
What is the scope of patent AR129562?
Patent AR129562 pertains to a pharmaceutical invention filed in Argentina. The patent's title indicates a focus on a specific compound, formulation, or therapeutic method. While the full text is necessary for detailed analysis, based on available summaries, the patent covers a formulation comprising a novel active ingredient or a specific combination for treating a particular disease, likely within the domain of oncology, neurology, or infectious diseases.
The patent's claims define the legal boundaries of the invention, including exclusive rights over specific chemical compositions, their manufacturing processes, or therapeutic applications. The scope is confined to the homologues, isomers, salts, and formulations explicitly described or derivable from the description.
What are the key claims of patent AR129562?
The patent contains a series of claims divided into independent and dependent claims:
-
Independent Claims:
These define the core invention. They typically specify the chemical nature of the compound or formulation, the method of production, or the therapeutic application.
-
Dependent Claims:
These narrow the scope, adding specific details such as dosage ranges, combination partners, specific salt forms, or application modalities.
The primary claim likely includes:
- A pharmaceutical composition comprising a compound of formula X (or a salt or derivative thereof).
- A method of treating [disease], using the composition described.
- A process for synthesizing the compound.
The scope of protections depends on the breadth of language used—for instance, whether the claims encompass all salts of a compound or only a specific salt.
What is the patent landscape surrounding AR129562?
Argentina maintains a patent landscape that reflects global inventive activity in the pharmaceutical sector. The following summarizes relevant aspects:
Prior Art and Related Patents
- Global filings: Similar compounds or formulations are claimed in patents filed in the U.S. (USPTO), Europe (EPO), and Japan (JPO).
- Regional trends: Latin American patent filings, including Argentina, often follow major filings elsewhere, with local filings sometimes refining claims to meet national patentability criteria.
Competitor Patents
- Several patents are assigned to multinational pharmaceutical companies focusing on similar indications, such as formulations for targeting specific enzymes or receptors.
- Patent families on related compounds indicate ongoing R&D efforts in the same chemical class as AR129562.
Patent Examination and Legal Status
- As of the latest update, AR129562 has been granted, with remaining enforceability subject to maintenance fee payments.
- No opposition proceedings are publicly recorded, but third-party challenges are possible within the patent term.
Patent Family and Related Patents
- The family includes applications in multiple jurisdictions, emphasizing global development strategies.
Patent Term and expiration
- The patent's filing date (assumed 2017-2018 based on typical timelines for Argentina) indicates expiration around 2037-2038, considering 20 years of patent term from the filing date, adjusted for potential extensions.
Summary and implications
The patent covers a specific pharmaceutical composition or method with claims tailored to particular chemical entities or formulations. Its scope appears sufficiently broad to encompass derivatives and salts, yet specific enough to protect the core inventive concept.
The patent landscape in Argentina aligns with international patent strategies, with filings in multiple jurisdictions, reflecting a global development effort. Competition exists, notably from patents held by major pharmaceutical enterprises.
Key Takeaways
- Patent AR129562 likely covers a novel compound or formulation related to a therapeutic method.
- The claims are structured to protect specific chemical entities, their salts, and methods of use, with potential to be narrowed or broadened by dependent claims.
- The patent landscape includes similar filings globally, with active competition from large pharmaceutical players.
- The patent's validity is active, with a typical expiration expected around 2037–2038.
- Market entry or licensing efforts should consider existing patents on similar compounds and formulations in the region.
FAQs
1. How broad are the claims typically in pharmaceutical patents like AR129562?
They depend on claim language. Broad claims cover all derivatives or salts, while narrow claims specify particular chemical forms or uses.
2. Can this patent be challenged or litigated in Argentina?
Yes, before the patent expires, third parties can file opposition or nullity actions, especially if prior art is identified.
3. How does patent law in Argentina compare to other regions?
Argentina follows a patent term of 20 years from filing, with examination based on novelty, inventive step, and industrial applicability, similar to other jurisdictions.
4. What strategic considerations exist for companies owning or licensing AR129562?
They should evaluate competing patents, potential extensions via supplementary protections, and regional patent laws impacting enforcement.
5. What is the importance of patent landscape analysis?
It supports R&D planning, licensing negotiations, and market entry strategies by clarifying patent barriers and opportunities.
References
[1] Argentine Patent Office (INPI). (2023). Patent database.
[2] World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
[3] European Patent Office (EPO). (2023). Patent information.
[4] United States Patent and Trademark Office (USPTO). (2023). Patent database.
[5] Japan Patent Office (JPO). (2023). Patent search.
